(Q39438609)

12 September 2017

title

Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death (English)

1 reference

12 September 2017

1 reference

1 reference

Pekka T Männistö

6

0 references

author name string

Bernardino Ossola

1

1 reference

12 September 2017

Tiina A Lantto

2

1 reference

12 September 2017

Katja A Puttonen

3

1 reference

12 September 2017

Raimo K Tuominen

4

1 reference

12 September 2017

Atso Raasmaja

5

1 reference

12 September 2017

publication date

23 November 2011

1 reference

Journal of Neuroscience Research

12 September 2017

published in

1 reference

12 September 2017

volume

90

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

682-690

1 reference

Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.

12 September 2017

cites work

1 reference

1-Nitropyrene (1-NP) induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells

21 January 2018

1 reference

Paraquat-induced oxidative stress in drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid.

21 January 2018

1 reference

Cell death independent of caspases: a review.

21 January 2018

1 reference

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.

21 January 2018

1 reference

Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline

21 January 2018

1 reference

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

21 January 2018

1 reference

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions

21 January 2018

1 reference

Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways

21 January 2018

1 reference

Minocycline: stain devil?

21 January 2018

1 reference

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

21 January 2018

1 reference

Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures

21 January 2018

1 reference

Lysosomes and autophagy in cell death control

21 January 2018

1 reference

Impairment of mitochondrial function by minocycline

21 January 2018

1 reference

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons

21 January 2018

1 reference

Pharmacokinetic studies on minocycline in man.

21 January 2018

1 reference

Ara-C induces apoptosis in monkey fibroblast cells.

21 January 2018

1 reference

The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.

21 January 2018

1 reference

Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

21 January 2018

1 reference

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

21 January 2018

1 reference

Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease

21 January 2018

1 reference

Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells

21 January 2018

1 reference

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways

21 January 2018

1 reference

Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells

21 January 2018

1 reference

Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease.

21 January 2018

1 reference

Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis.

21 January 2018

1 reference

An alternative, nonapoptotic form of programmed cell death

21 January 2018

1 reference

Identification of new modulators and protein alterations in non-apoptotic programmed cell death

21 January 2018

1 reference

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

21 January 2018

1 reference

Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration

21 January 2018

1 reference

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system

21 January 2018

1 reference

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

21 January 2018

1 reference

Minocycline enhances MPTP toxicity to dopaminergic neurons

21 January 2018

1 reference

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.22791

1 reference

12 September 2017

1 reference